'Doctor prescribed, concierge support, free shipping direct to your door' (Forbes card copy); homepage markets GLP-1 weight loss plus NAD+ and sermorelin lines.
Read: broad adult longevity + weight-loss consumer; NAD+ positioning skews self-optimization.
Product tables: semaglutide $229 first/$249 ongoing, tirzepatide $295/$315; campaign and header prices differ. Full longevity catalog below.
US-licensed clinicians advertised; treating medical-group legal names not established.
US pharmacy fulfillment advertised; specific dispensing partners and ownership not established. FDA-registered wording is a vendor claim, not approval of compounded drugs.
US last-30-days domain lookup, 15 Oct 2026: 0 counter, 3 retained cards. Advertiser labels: Ready Health Ventures, Inc.. Counter/grid inconsistencies and historical retained cards are not active-ad or spend proof. US active exact-keyword lookup, 15 Oct 2026: about 420 keyword results, mixed ReadyRx and Jazmin P pages; not a brand-only total. Samples 2114934486080880 started 28 Aug, 1424716306275374 started 23 Sep.
- https://adstransparency.google.com/?region=US&domain=readyrx.com&preset-date=Last+30+days ↗
- https://www.facebook.com/ads/library/?active_status=active&ad_type=all&country=US&is_targeted_country=false&media_type=all&q=%22ReadyRx%22&search_type=keyword_exact_phrase ↗
- https://www.linkedin.com/ad-library/search?accountOwner=ReadyRx ↗
Not established from reviewed free public sources as of 15 Oct 2026.
Daniel Rudyak, co-founder (independent podcast biography). Steven Rak discusses creating ReadyRx in a separate podcast; complete founder roster not established.
Westwood, Los Angeles (LinkedIn-listed headquarters).
Public search snapshot, 15 Oct 2026: NAD+ | ReadyRx; Longevity, Weight & Performance Solutions | ReadyRx; GLP-1s: Are they even Effective? | Blog | ReadyRx; ReadyRx | GLP-1. Free site-restricted discovery only; search ranking, traffic, volume and authority are not measured.